| 6FEC 100 | 3FEC/3D |
---|---|---|
Amenorrhea at the end of chemotherapy | 78 (93 %) | 65 (92.8 %) |
Clinically reversible amenorrhea (n = 154) | Â | Â |
   Total population** | 20/84 (23.7 %) | 25/70 (35.5 %) |
   Patients < 40 years (39) | 13/18 (72 %) | 15/21 (71.4 %) |
   Patients ≥ 40 years (115)** | 7/66 (10.5 %) | 10/49 (20.5 %) |
Recovery of premenopausal hormone values * | Â | Â |
   Total population (n = 101)** | 18/59 (29 %) | 18/42 (42 %) |
   Patients < 40 years (31) | 11/15 (73.3 %) | 12/16 (75 %) |
   Patients ≥ 40 years (70)** | 6/42 (14 %) | 6/28 (21.4 %) |
Clinically reversible amenorrhea. No hormone values available (n = 53) | Â | Â |
   Patients < 40 years (8) | 2/3 (66 %) | 3/5 (60 %) |
   Patients ≥ 40 years (45)** | 1/24 (4 %) | 4/21 (19 %) |